tiprankstipranks
Advertisement
Advertisement

AGEN Stock Latest News

Agenus files to sell 2.13M shares of common stock for holders
The FlyAgenus files to sell 2.13M shares of common stock for holders
3d ago
AGEN
Top 3 Penny Stocks to Watch after Massive Trading Volume, 7/14/2026
PremiumMarket News
Top 3 Penny Stocks to Watch after Massive Trading Volume, 7/14/2026
9d ago
AGEN
SOBR
Why Is Agenus (AGEN) Stock Up Today?
PremiumMarket News
Why Is Agenus (AGEN) Stock Up Today?
10d ago
AGEN
Agenus price target raised to $30 from $23 at H.C. Wainwright
PremiumThe Fly
Agenus price target raised to $30 from $23 at H.C. Wainwright
10d ago
AGEN
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
PremiumThe Fly
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
10d ago
AGEN
Agenus Secures Strategic Financing to Advance Colon Cancer Program
PremiumCompany AnnouncementsAgenus Secures Strategic Financing to Advance Colon Cancer Program
10d ago
8K
AGEN
Agenus announces $340M private placement
Premium
The Fly
Agenus announces $340M private placement
10d ago
AGEN
LGND
Agenus Extends Debt Maturities and Warrant Expirations
Premium
Company Announcements
Agenus Extends Debt Maturities and Warrant Expirations
17d ago
8K
AGEN
Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI
PremiumThe Fly
Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI
17d ago
AGEN
Agenus announces three-year survival data from Phase 1b BOT+BAL study
PremiumThe Fly
Agenus announces three-year survival data from Phase 1b BOT+BAL study
28d ago
AGEN
Agenus Shareholders Approve Governance, Compensation and Auditors
PremiumCompany Announcements
Agenus Shareholders Approve Governance, Compensation and Auditors
30d ago
8K
AGEN
Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
PremiumCompany Announcements
Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
1M ago
AGEN
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News5 Healthcare Stocks Set to Join the Russell 3000
2M ago
QSI
AGEN
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
Premium
Ratings
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
2M ago
AGEN
Agenus Announces Resignation of Principal Accounting Officer
Premium
Company Announcements
Agenus Announces Resignation of Principal Accounting Officer
2M ago
8K
AGEN
Agenus announces publication of Phase 1b BOT+BAL data
PremiumThe Fly
Agenus announces publication of Phase 1b BOT+BAL data
2M ago
AGEN
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
PremiumRatings
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
2M ago
AGEN
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe Fly
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
2M ago
BW
GM
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
PremiumThe Fly
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
2M ago
AGEN
Agenus provides 2026 strategic priorities
PremiumThe FlyAgenus provides 2026 strategic priorities
2M ago
AGEN
Agenus announces conclusion of SEC investigation with no enforcement action
Premium
The Fly
Agenus announces conclusion of SEC investigation with no enforcement action
2M ago
AGEN
AGEN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AGEN Earnings this Week: How Will it Perform?
3M ago
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >